RB1 and retinoblastoma: RB1-null human embryonic stem cells, generated using CRISPR/Cas9, were shown to form large teratomas with characteristics similar to trilateral retinoblastoma tumors and were proposed as a platform for studying mitochondrial phenotyping, in vivo tumorigenesis, and drug screening [116].